Most Recent
IP Australia has rejected a patent application by financial software firm Intuit, finding that its invention was not a manner of manufacture and contained "nothing of substance" from which patentable claims could be found.
Two Italian cheese consortiums have failed in separate bids to trade mark their respective cheeses, Gorgonzola and Asiago, with delegates ruling the trade marks were not capable of distinguishing each consortium’s products from other cheeses.
Generic drug maker Juno Pharmaceuticals has agreed to stopped planned sales of its cheap version of Millennium Pharmaceuticals anti-cancer medication Velcade in Australia as part of a settlement of its lawsuit alleging two patents covering the drug were invalid.
The Dutch coffee company behind the popular Moccona brand has successfully opposed a coffee capsule patent sought by coffee machine maker K-fee.
A US communications infrastructure company has filed a patent lawsuit against the Australian arm of French energy tech giant Schneider Electric, which is accused of flagrant infringement with the sale of one of its Clipsal electric socket products.
Monster Energy has launched another Federal Court case against Vittoria Food & Beverage seeking to block the coffee maker from trading on the popularity of its Mother energy drink brand, and the beverage giant will have to convince the court that its brand is not so strong that confusion among consumers is not likely.
Monster Energy has lost its opposition to coffee company Vittoria Food & Beverage's proposed 'Mothersky' trade mark, with a delegate of the Trade Marks Office saying the energy drink company's 'Mother' energy drink brand was so strong in the minds of consumers that there was no likelihood of confusion.
Beverage giant Monster Energy has launched a Federal Court challenge to the removal of its 'mother loaded iced coffee' trade mark, part of a portfolio of Mother energy drink-related marks acquired from Coca Cola in 2015.
Generic drug maker Juno Pharmaceuticals and US-based Millennium Pharmaceuticals have reached an in-principle settlement in their trans-Pacific dispute over two patents covering breakthrough anti-cancer medication Velcade.
Explosives maker Dyno Nobel has reached a mid-trial settlement in its case against its major rival, Orica, over a patent for a method for blasting rock at open cut mines.